Literature DB >> 25686142

A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.

P M Ricks1, R C Hershow1, A Rahimian2, D Huo3, W Johnson4, N Prachand5, A Jimenez1, W Wiebel1, W Paul6.   

Abstract

SETTING: Chicago Department of Public Health (CDPH), TB Control Program.
OBJECTIVES: To compare anti-tuberculosis treatment outcomes using two different types of directly observed therapy (DOT) outreach workers.
METHODS: Substance users diagnosed with TB from October 1996 to July 2000 were randomized to DOT administered by either 1) CDPH personnel (standard arm) or 2) previous substance-using human immunodeficiency virus/acquired immune-deficiency syndrome outreach workers (enhanced arm). Treatment completion was physician-determined, and adherence was estimated based on risk of missed DOT appointments.
RESULTS: Of 94 patients, 46 were randomized to the standard and 48 to the enhanced arm. The standard arm had a significantly higher risk of non-completion of treatment (39% vs. 15%, RR 2.7, 95%CI 1.2-5.8), and a significantly higher risk of missing DOT appointments (RR 2.6, 95%CI 1.4-4.8). For both outcomes, housing instability was a significant predictor in multivariate analyses.
CONCLUSIONS: TB treatment completion and adherence among substance users was improved by the enhanced intervention; the familiarity of enhanced-arm DOT workers with the patients' social norms due to their own previous substance use may have made them more effective. Successful DOT in hard-to-reach populations may require strategies that directly address the population's circumstances and utilize DOT workers who are intimately familiar with patients' life situations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25686142     DOI: 10.5588/ijtld.14.0471

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Double trouble: tuberculosis and substance abuse in Nagaland, India.

Authors:  R Shenoy; M Das; H Mansoor; R Anicete; L Wangshu; S Meren; I Ao; P Saranchuk; A J Reid; P Isaakidis
Journal:  Public Health Action       Date:  2015-09-21

2.  Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".

Authors:  Eric R Braverman; Catherine A Dennen; Mark S Gold; Abdalla Bowirrat; Ashim Gupta; David Baron; A Kenison Roy; David E Smith; Jean Lud Cadet; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

3.  Substance use disorders and adherence to antituberculosis medications in Southwest Ethiopia: a prospective cohort study.

Authors:  Matiwos Soboka; Markos Tesfaye; Kristina Adorjan; Wolfgang Krahl; Elias Tesfaye; Yimenu Yitayih; Ralf Strobl; Eva Grill
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

4.  Patient support for tuberculosis patients in low-incidence countries: A systematic review.

Authors:  Sarah van de Berg; Niesje Jansen-Aaldring; Gerard de Vries; Susan van den Hof
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.